The third Macra SKU is already in final development for hormonal / cycle support. This is the category analysis: why the timing is right, where the competition is weak, and how to position the product so it doesn't get lost in a noisy shelf.
Unlike heart health (where the question is should we?), this one is already in motion. The real question is: how do we win a category that's suddenly getting crowded, and how do we avoid looking like every other femtech supplement on the shelf?
Perimenopause/menopause broke out of the clinical closet in the last 3 years. Mel Robbins, Oprah, Halle Berry, Naomi Watts — all producing content that has normalized talking about hormones, cycles, and cortisol in everyday vocabulary. What was whispered is now TikTok content.
25–35 year old women are tracking follicular, ovulatory, luteal phases like athletes track macros. Apps (Flo, Clue, Natural Cycles) have trained millions to think of their cycle as a performance variable, not a problem to suppress.
Millions of women are coming off hormonal birth control and looking for support. They don't want pharma. They want natural, trusted, transparent — exactly Macra's voice.
"Cortisol face," "cortisol belly," adaptogens — stress hormones are now discussed as a health metric. Any hormonal SKU that nails cortisol + cycle together is riding two wellness trends in one bottle.
Moody, Flo, Needed, O Positiv, Winona, Beli, HUM, Perelel, Wile, Kindra, Mezo. This is not empty white space — this is a battle royale. Differentiation has to be sharp.
Every brand says it. The copy on every bottle blurs together: "supports hormonal balance, reduces PMS, boosts mood." If Macra's SKU copy sounds like everyone else's, we lose.
Cycle support (20s–30s), fertility (30s), perimenopause (40s), menopause (50s) are four different buyers with four different problems. Picking one sharpens the brand; trying to do all four dilutes it.
Vitex, ashwagandha, magnesium glycinate, evening primrose oil, chasteberry, DIM — every brand uses the same handful. The ingredient story alone won't differentiate.
My recommendation: cycle support for women 25–40 who aren't trying to get pregnant and aren't in peri yet. This is the biggest underserved segment — too old for Gen Z cycle apps, too young for the Halle Berry menopause brands. Macra's lifestyle-forward tone fits this buyer perfectly.
Differentiate with a product experience that maps to the four cycle phases. Even if it's one SKU, the content + education + packaging can teach phase awareness. This turns a commoditized category into a ritual — which is exactly Macra's positioning.
"Hormonal balance" is tired copy. Reframe as stress + cycle resilience. Cortisol disruption affects progesterone, which affects mood, sleep, and PMS. This narrative is fresh, clinically credible, and naturally laddered up from Mood Bloom.
Mood Bloom (saffron, L-theanine, rhodiola) and the new hormonal SKU should be designed to stack. Marketed as a duo: one for daily mood, one for cycle resilience. This becomes Macra's signature female ritual and drives AOV + LTV hard.
Final formula is Myles's call — this is a brand/positioning lens, not a formulation rec. Directional pairings that tell a strong story:
| Ingredient | Story | Clinical strength |
|---|---|---|
| Vitex (Chasteberry) | Classic cycle herb, proven PMS reduction | Strong |
| Maca (gelatinized) | Energy + libido, adaptogenic | Moderate |
| Ashwagandha (KSM-66) | Cortisol reduction, stress resilience | Strong |
| Magnesium glycinate | PMS, sleep, mood | Strong |
| Dong Quai / Shatavari | Differentiated, "ancient wisdom" story | Moderate |
Avoid DIM and I3C — saturated by competitors and harder to position cleanly. [For Myles to validate]
Macra's two-word pattern (Mood Bloom, Carb Curb) needs to continue. Candidates in that voice:
Trademark check and domain availability required before any of these lock. Need Myles / legal to run searches.
Market sizing is directional. Commission firmer numbers before Q3. [UNVERIFIED]
| Brand | Positioning | Weakness |
|---|---|---|
| Moody | PMS-specific, Gen Z tone | Too young, too narrow |
| O Positiv | Broad women's health, direct | Category-generic copy |
| Perelel | Life-stage stacks, doctor-led | Clinical tone, not lifestyle |
| Needed | Fertility-focused, premium | Narrow to fertility journey |
| Wile | Perimenopause, 40+ | Age-specific, not for 25–40 |
| Macra white space | 25–40 cycle-aware, stacks with Mood Bloom | — |
Don't play in perimenopause (crowded, wrong demo for Macra's tone). Don't play in fertility (too narrow, wrong positioning). The 25–40 cycle-aware professional — the woman who tracks her phases, listens to Huberman, is off the pill, and wants her supplement routine to feel like a ritual — is Macra's buyer.
Lead positioning: cortisol + cycle resilience. Bundle strategy: Mood Bloom + new SKU as a duo. Name direction: two-word, cycle-forward, not medical.
Status: Greenlight on direction. Need Myles to validate formula, legal to clear names, Dylan to start packaging/site work in parallel.